000 01408 a2200385 4500
005 20250513031158.0
264 0 _c19941116
008 199411s 0 0 eng d
022 _a0028-1298
024 7 _a10.1007/BF00180018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchleuning, M
245 0 0 _aInhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives.
_h[electronic resource]
260 _bNaunyn-Schmiedeberg's archives of pharmacology
_cJul 1994
300 _a100-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCell Division
650 0 4 _aCell Line
650 0 4 _aCells, Cultured
650 0 4 _aChlorpromazine
_xpharmacology
650 0 4 _aCyclosporine
_xpharmacology
650 0 4 _aFluphenazine
_xpharmacology
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xbiosynthesis
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aReceptors, Interleukin
_xmetabolism
650 0 4 _aReceptors, Interleukin-2
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aT-Lymphocytes
_xdrug effects
650 0 4 _aTacrolimus
_xpharmacology
700 1 _aBrumme, V
700 1 _aWilmanns, W
773 0 _tNaunyn-Schmiedeberg's archives of pharmacology
_gvol. 350
_gno. 1
_gp. 100-3
856 4 0 _uhttps://doi.org/10.1007/BF00180018
_zAvailable from publisher's website
999 _c7523425
_d7523425